# SubscriberWrites: From Shiva to Science: India’s Uneasy Relationship with Cannabis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/india-cannabis-policy-changes-tradition-science/ > **Published:** 2026-04-13T04:07:27-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:23:51-04:00 > **Clinical Summary:** Explore India cannabis policy changes and their impact on global research and patient care in this detailed clinical relevance update. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Global PolicyCultural MedicineRegulatory FrameworkInternational ResearchPatient Perspectives Why This Matters India’s evolving cannabis policy landscape affects global research access and patient care options for one of the world’s largest populations. Understanding cultural and regulatory frameworks helps clinicians contextualize patient perspectives and anticipate shifts in international [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) development. Clinical Summary India maintains complex cannabis regulations that reflect tensions between traditional religious use, colonial-era prohibitions, and emerging scientific interest. While recreational use remains largely prohibited, traditional preparations like bhang retain cultural acceptance in certain contexts. The regulatory environment continues to evolve as scientific evidence accumulates, though clinical access remains limited compared to Western markets. Dr. Caplan’s Take “Cultural context profoundly shapes patient attitudes toward [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) — understanding a patient’s background helps me frame therapeutic discussions more effectively. India’s regulatory evolution will likely influence global [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) and access patterns significantly.” Clinical Perspective 🧠 Clinicians treating patients from diverse cultural backgrounds should inquire about traditional cannabis exposure and cultural attitudes. This helps inform therapeutic discussions and dosing considerations. Monitor international regulatory developments as they may affect future research directions and treatment options. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20SubscriberWrites%3A%20From%20Shiva%20to%20Science%3A%20India%27s%20Uneasy%20Relationship%20with%20Cannab...%20%40drcaplan&url=https%3A//theprint.in/yourturn/subscriberwrites-from-shiva-to-science-indias-uneasy-relationship-with-cannabis/2903404/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//theprint.in/yourturn/subscriberwrites-from-shiva-to-science-indias-uneasy-relationship-with-cannabis/2903404/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20SubscriberWrites%3A%20From%20Shiva%20to%20Science%3A%20India%27s%20Uneasy%20Relationship%20with%20Cannab...%20--%20via%20%40drcaplan.bsky.social%20https%3A//theprint.in/yourturn/subscriberwrites-from-shiva-to-science-indias-uneasy-relationship-with-cannabis/2903404/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://theprint.in/yourturn/subscriberwrites-from-shiva-to-science-indias-uneasy-relationship-with-cannabis/2903404/](https://theprint.in/yourturn/subscriberwrites-from-shiva-to-science-indias-uneasy-relationship-with-cannabis/2903404/) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What topics does this cannabis news update cover?](#What_topics_does_this_cannabis_news_update_cover) - [Why is this classified as “Notable Clinical Interest”?](#Why_is_this_classified_as_8220Notable_Clinical_Interest8221) - [What is the significance of the “New” designation?](#What_is_the_significance_of_the_8220New8221_designation) - [How does this relate to clinical cannabis practice?](#How_does_this_relate_to_clinical_cannabis_practice) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system rates cannabis-related developments on their clinical importance, with #70 indicating “Notable Clinical Interest.” This classification identifies emerging findings or policy developments that healthcare professionals should monitor closely. #### What topics does this cannabis news update cover? This update focuses on four key areas: Global Policy developments, Cultural Medicine practices, Regulatory Framework changes, and International Research initiatives. These represent the most significant areas of current cannabis policy and research activity worldwide. #### Why is this classified as “Notable Clinical Interest”? The #70 rating indicates emerging findings or policy developments that have potential clinical implications worth monitoring. This suggests the content may influence future cannabis treatment protocols or regulatory approaches in healthcare settings. #### What is the significance of the “New” designation? The “New” label indicates this is recently published information that hasn’t been previously reported. This ensures healthcare professionals and researchers are accessing the most current developments in cannabis policy and research. #### How does this relate to clinical cannabis practice? Updates on global policy, regulatory frameworks, and international research directly impact [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) practice by influencing treatment guidelines, legal frameworks, and evidence-based approaches. These developments help shape how healthcare providers can legally and effectively incorporate cannabis medicine into patient care. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Mass. cannabis law could take effect before 4/20 — here's what changes](https://cedclinic.com/massachusetts-cannabis-regulatory-changes-2026/) Learn about upcoming cannabis law changes in Massachusetts and their potential impact on patient access and regulation. [Read More](https://cedclinic.com/massachusetts-cannabis-regulatory-changes-2026/) [Opinion: What cannabis legalization looks like in New York today](https://cedclinic.com/new-york-cannabis-legalization-implementation/) Explore the current landscape of [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) in New York and its implications for patients and clinicians. [Explore Now](https://cedclinic.com/new-york-cannabis-legalization-implementation/) [Cannabis Provides Help For Patients With Chronic Pain, Anxiety, and Depression](https://cedclinic.com/cannabis-chronic-pain-anxiety-depression-evidence/) Review clinical insights on cannabis use for managing chronic pain, anxiety, and depression in diverse patient populations. [Learn More](https://cedclinic.com/cannabis-chronic-pain-anxiety-depression-evidence/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).